Presenter: G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD
In episode 485, Mike and James go over a couple of COVID trials that show two different anti-inflammatories – colchicine and inhaled budesonide – seem to have an effect on reducing hospitalizations or urgent care visits. 1) Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial Lancet…
BS Medicine Episode #624: PCSK9 Inhibitors: Cardiovascular prevention panacea or pricey pokes?
FM Rounds #20: Accompagner les personnes trans et non binaires en médecine familiale
FM Rounds #19: Coming Home: Post-op Gender Affirming Surgery in Primary Care
Presenter(s):
G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD








Please provide any additional comments (optional).